Keywords: taro, generic, levetiracetam, cleared, fda, subsidiary, israel

Taro's generic levetiracetam cleared by US FDA

Article | 16 February 2009

Print This

The US subsidiary of Israel's Taro Pharmaceutical has received approval from the Food and Drug Administration for its Abbreviated New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in